Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion
Lee S. Rosen, David H. Gordon, William Dugan Jr., Pierre Major, Peter D. Eisenberg, Louise Provencher, Mary Kaminski, Joe Simeone, John Seaman, Bee-Lian Chen, Robert E. ColemanVolume:
100
Year:
2004
Language:
english
Pages:
8
DOI:
10.1002/cncr.11892
File:
PDF, 131 KB
english, 2004